glp-1 analogues list Drug Comparison in Diabetes and Obesity Treatment This review summarizes how GLP-1

Current oral users commonly cite convenience and a preference to avoid injections as their primary reasons for taking a pill

e5981971

If approved for the treatment of obesity, orforglipron could provide a convenient alternative for the millions of individuals living with obesity around the globe to continue their long-term health journey, said Kenneth Custer, executive vice president at Eli Lilly and president of Lilly Cardiometabolic Health, in a statement from the company

Most patients require long-term or indefinite GLP-1 therapy to maintain benefits, as discontinuation typically results in weight regain and worsening metabolic parameters